vascular surgery News
-
Showcase
Discover Dr. Kasuo Miyake’s Innovative CLaCS Procedure
Kasuo Miyake, MD-PhD, is one of the world’s leading vascular surgeons, respected for his contribution to the development of new techniques for different types of varicose vein treatment. Based on his doctoral thesis, he created the CLaCS technique along with his father, and pioneered the use of augmented reality, like VeinViewer‘s near-infrared technology, in the treatment of micro ...
-
Vascular experts discuss aXess in dialysis patients
Vascular surgeon and professor of vascular surgery at Università dell’Insubria in Italy, and Frans L. Moll, MD, PhD, professor emeritus of vascular surgery at the University Medical Center Utrecht in The Netherlands, provided insights on the progress of the aXess trial in an interview with Healio Nephrology. For more on Xeltis’ aXess, the first restorative synthetic ...
By XELTIS BV
-
Stanford Surgeon Venita Chandra Joins Alucent Biomedical Scientific Advisory Board as Company Enters Arteriovenous Fistula Market
Alucent Biomedical, a privately held medical technology company founded to transform the way vascular disease is treated, today announced Venita Chandra, M.D., will join the company’s scientific advisory board. Dr. Chandra is board certified in both general and vascular surgery. She is a clinical associate professor of surgery in the Division of Vascular Surgery at Stanford University ...
-
First Ever Standard Surgical Risk Patient TCAR Data to be Presented at the Society for Vascular Surgery 2021 Vascular Annual Meeting
Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced that key data regarding standard risk patients undergoing treatment for atherosclerotic carotid disease, including patients undergoing carotid endarterectomy (CEA) and transcarotid artery revascularization (TCAR), will be presented at the upcoming Society for ...
-
New interview released about Automated CO2 Angiography technology in India – PGIMER Chandigarh
Prof. M.S Sandhu from PGIMER Chandigarh #Radiology Department – India. recently gave an interview in which he illustrated the peculiarities of automatic CO2 angiography. In this interview, Prof. Sandhu remarked the Angiodroid technology. Here is a brief excerpt: “A recently developed injector with a very novel method to map these vessels is to use carbon dioxide as a ...
-
TISSIUM Receives FDA Investigational Device Exemption for Vascular Sealant
TISSIUM, a privately-owned medtech company developing biomorphic programmable polymers for tissue reconstruction, announced today it has received approval from the U.S. Food and Drug Administration for its Investigational Device Exemption application for its vascular sealant. The approval is the most recent validation of TISSIUM’s efforts to develop a unique platform of proprietary ...
By TISSIUM
-
Centerline Biomedical Completes First Human Patient in the United States with IOPS™ (Intra-Operative Positioning System)
Surgical navigation startup Centerline Biomedical, Inc. (Centerline), a Cleveland Clinic spin-off company, has announced the successful completion of the first in a series clinical cases in the United States as it begins limited launch of its innovative IOPS™ technology platform. The FDA-cleared technology is being deployed at Cleveland Clinic to begin, with other leading institutions to ...
-
Centerline Biomedical Announces First-in-Human Use of IOPS™ Intra-Operative Positioning System
Centerline Biomedical, Inc., a spinout company from Cleveland Clinic, announced the successful first human clinical use of its groundbreaking IOPS™ technology. IOPS, the Intra-Operative Positioning System, provides doctors performing minimally-invasive vascular repairs with an intuitive, interactive color 3D display. Used in conjunction with standard 2D grayscale X-ray fluoroscopy ...
-
Marizyme Announces Approval for DuraGraft in India
Marizyme, Inc. (OTCQB:MRZM), a publicly traded global biotechnology company developing products to reduce the burden of ischemia-reperfusion injury in tissue grafting, organ transplant, and other surgical indications, announced today that its flagship product DuraGraft® is now registered and licensed for import into India through Marizyme's distribution partner Regency Lifesciences. India ...
-
Centerline Biomedical Awarded $1.5M Phase II NIH SBIR Grant to Advance Development of Next-Generation IOPS Technology
Centerline Biomedical, Inc. (Centerline) announced on April 21, 2020 the receipt of a Direct to Phase II Small Business Innovation Research (SBIR) grant award from the National Heart, Lung, and Blood Institute of the National Institutes of Health (NIH). This represents the fourth small business grant awarded to the startup founded to commercialize and innovate IOPS™, a novel image guidance ...
-
SymphonyAI Company TeraRecon Appoints Dan McSweeney President
Advanced visualization and AI leader TeraRecon, a SymphonyAI company, today announced the appointment of Dan McSweeney as president. He will be responsible for continuing and expanding TeraRecon's leadership in healthcare advanced visualization and enterprise AI. "TeraRecon is known for its strong reputation as the leader in advanced visualization and AI innovation in healthcare," said ...
-
Inari Medical Announces Randomized Controlled Trial Evaluating Clinical Outcomes of the ClotTriever System in Deep Vein Thrombosis
Inari Medical, Inc. (NASDAQ: NARI) (“Inari”) a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, announced planned enrollment of the DEFIANCE trial. DEFIANCE is a randomized controlled trial (“RCT”) comparing the clinical outcomes of patients with iliofemoral deep vein thrombosis ...
-
Bluegrass Vascular Announces Featured Paper in the Journal of Vascular Surgery Reporting on the Use of the Surfacer System
Bluegrass Vascular Technologies, a private medical technology company focused on innovating lifesaving devices and methods for vascular access procedures, announced today the publication of a paper featured on the cover of the June 2022 issue of the Journal of Vascular Surgery (JVS) which reports on the use the Surfacer System to perform an Inside-Out® procedure to obtain central venous ...
-
Marizyme Announces Expansion of Patent Portfolio Into Several Key Territories
Marizyme Inc. (MRZM), a biotechnology company engaged in the development and commercialization of advanced healthcare products to prevent, treat and diagnose diseases of unmet clinical need, announced today that it has received notice of allowance for foundational patent applications for two of its core technologies in several key markets further strengthening the company’s intellectual ...
-
Saluda Medical Appoints Doug Godshall as Chairman of the Board
Saluda Medical Pty Limited (“Saluda Medical”), a global medical device company on a mission to revolutionize the field of neuromodulation with an emerging portfolio of therapies driven by advanced closed-loop technologies designed to treat debilitating neurological disorders, today announced the appointment of Doug Godshall as Chairman of its Board of Directors. Mr. Godshall succeeds ...
-
TeraRecon Announces DocPanel Signs Contract for Intuition Titanium, Reaffirming its Cardiothoracic Imaging Service Commitment
TeraRecon, a ConcertAI company and a leader in advanced medical visualization using AI to improve patient care, today announced U.S.-based DocPanel, the world’s first radiology marketplace offering access to over 500 fellowship trained radiologists available for radiological reads, second opinions, and educational consults, has signed a contract for TeraRecon’s advanced visualization ...
-
Sonavex Receives FDA 510(k) Clearance for EchoSure
Sonavex, Inc., a privately held medical device company focused on empowered patient care, announced today that on March 8, 2019 it received 510(k) clearance from the U.S. Food and Drug Administration for its EchoSureTM device to deliver definitive blood flow data on demand. The EchoSure system combines 3D ultrasound imaging with advanced deep learning algorithms to automate visual and ...
-
NIH Awards Sonavex, Inc. $3 Million Grant to Pursue New Vascular Surgery Applications for EchoMark & EchoSure
Sonavex, Inc., a privately held medical device company focused on empowered patient care, announced that it received a $3 million Phase IIB Small Business Innovation Research (SBIR) grant from the National Institutes of Health to use its EchoMark & EchoSure devices to support arteriovenous (AV) fistula maturation and long-term viability. The award provides capital for prospective clinical ...
-
Announcing Key Leadership Team Additions and Scientific Clinical Advisory Board Formation
Advanced Oxygen Therapy Inc. (AOTI), the leader in noninvasive sustained wound healing solutions, announced today a number of significant additions to its Leadership Team, bringing to the company over 100 years of combined strategic experience: Chief Medical Officer – Dr. Matthew G. Garoufalis is Co-Chair of the Alliance of Wound Care Stakeholders and past President of both the American ...
-
Bluegrass Vascular Announces New Paper Reporting Ability to Eliminate Use of a Femoral Catheter with the Surfacer System
Bluegrass Vascular Technologies, a private medical technology company focused on innovating lifesaving devices and methods for vascular access procedures, announced today the publication of a case report demonstrating the ability to utilize the Surfacer® System to perform the Inside-Out® procedure and obtain right-sided central venous access in a patient with central venous occlusion and ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you